Oura, the smart ring maker that turned quiet overnight biometric tracking into a mainstream wellness habit, introduced its first proprietary large language model in April 2026, built specifically to handle women’s health questions inside its existing AI assistant, Oura Advisor. Rather than relying on a general-purpose chatbot bolted onto its app, the company trained a dedicated model on established medical standards and research reviewed by its own board-certified clinicians and women’s health experts, then wired it directly into users’ long-term biometric trends.
An Assistant That Already Existed, Now Sharper
Oura Advisor itself launched earlier, on March 31, 2025, as an in-app assistant that interprets a user’s sleep, activity, readiness, and resilience data in plain language rather than leaving people to puzzle over raw graphs. Users can adjust its tone between conversational and direct and set how often it checks in. The April 2026 update layered a dedicated women’s health model on top of that foundation, aimed at questions around cycle tracking, hormonal patterns, and other topics where general health chatbots have historically performed poorly due to thin or generic training data.
The Numbers Behind the Rollout
Oura says the feature has already seen meaningful engagement: during Oura Labs testing, users sent more than a million messages to the assistant, with 83% rating the answers reliable, 60% reporting weekly usage, and just over half saying they noticed a tangible health benefit. Johanna Still, Oura’s UX Writing Manager and Head of Insights, describes Advisor’s role plainly: it’s meant to be an “in-app health and wellbeing assistant” that helps users understand what their numbers actually mean, rather than just displaying them. A built-in “memory” function lets the assistant retain a user’s personal health context across conversations, similar to features Whoop has since rolled out with its own My Memory tool.
Why Women’s Health Specifically
The decision to build a dedicated model rather than expand the general assistant reflects a well-documented gap in health technology: most consumer health apps and even many clinical AI tools are trained on datasets that underrepresent conditions specific to women’s health, from menstrual cycle variability to menopause-related symptoms and their interaction with sleep and recovery metrics that a ring can actually measure. By narrowing the model’s scope and having it reviewed by clinicians with specific expertise in that domain, Oura is betting that a smaller, more curated dataset produces more trustworthy answers than a general-purpose assistant stretched across every possible health topic.
An Honest Disclaimer Buried in the Announcement
Oura’s own materials don’t oversell the tool. The company acknowledges plainly that, “like all current LLM-based assistants, Advisor can make mistakes and is still growing in its knowledge” — a caveat that matters given how personal and consequential women’s health questions can be. It’s a tacit admission that even a purpose-built, clinician-reviewed model isn’t immune to the hallucination and confidence-without-accuracy problems that plague large language models generally, and it puts pressure on Oura to keep refining the tool rather than treating its April 2026 launch as a finished product.
A Crowded and Competitive Wearable Market
Oura isn’t alone in racing toward AI-driven health coaching. Whoop, its most direct competitor in the premium wearable space, announced its own expanded AI coaching tools and on-demand doctor video consultations for rollout in summer 2026. The near-simultaneous moves signal that AI interpretation of biometric data — not just sensor accuracy — has become the primary battleground for differentiating rings and bands that otherwise measure largely similar things. Where Oura is leaning into a narrow, clinically-reviewed specialty model, Whoop is leaning into personal context and human clinician access, two different bets on what users actually want from an AI health coach.
The Bigger Research Backdrop
The push toward smarter wearable interpretation comes as academic researchers are also mining wearable data at unprecedented scale. A National Institutes of Health preprint published in January 2026 analyzed 11 million days of Fitbit data from more than 29,000 All of Us Research Program participants and found that longer observation windows — a full year of step data, for instance — produced far more robust associations with disease outcomes than single-day snapshots, including novel links to chronic pain and autoimmune conditions. That kind of large-scale validation work, done independently of any single wearable company, is exactly the sort of evidence base that consumer AI health assistants like Oura Advisor have not yet had to clear.
What’s Next
Oura’s women’s health model is likely just the first of several specialized additions the company builds into Advisor, given how much variation exists across different health domains and populations. Whether narrower, clinically-curated models genuinely outperform larger general-purpose ones on accuracy — and whether Oura’s own reliability numbers hold up under independent scrutiny rather than self-reported user testing — will shape how much trust consumers place in ring-based AI health guidance going forward.
